Controlling Chemsex
Controlling Chemsex CIC, Controlling Chemsex CIO
- Country
- England & Wales
- Charity number
- 1197081
- Status
- Registered
- Registered
- Dec. 13, 2021
- Legal form
- CIO
Address
- Address
- 95 Mortimer street
London
W1W 7GB
Contact
- Phone
- +447718618671
- [email protected]
- Website
controllingchemsex.com
Activities
Promote and protect the health of individualssuffering from involvement in Chemsex behaviours with a particular focus on the LGBTQ community by:- Providing advice, information and support to them and others affected by their involvement;- Providing psychosexual therapy;- Raising awareness in society of the issues arising from Chemsex.
Objects: The Objects For The CIO Are For Public Benefit, To Promote And Protect The Health Of Individuals Suffering From Involvement In Chemsex Behaviours With A Particular Focus On The LGBTQ+ Community By:-Providing Advice, Information And Support To Them And Others Affected By Their Involvement;- Providing Psychosexual Therapy;- Raising Awareness In Society Of The Issues Arising From Chemsex.in These Objects “chemsex” Is The Use Of Drugs Before Or During Planned Sexual Activity To Sustain, Enhance, Disinhibit Or Facilitate The Experience. Chemsex Commonly Involves Crystal Methamphetamine, Ghb/gbl And Mephedrone, And Sometimes Injecting These Drugs (also Known As Slamming).
Classification
- How
- Provides Services, Provides Advocacy/advice/information
- What
- General Charitable Purposes, The Advancement Of Health Or Saving Of Lives, Disability, Other Charitable Purposes
- Who
- Other Defined Groups, The General Public/mankind
Areas of operation
- Country
- Northern Ireland, Scotland
- Region
- Throughout England And Wales
Finances
| Period end | Income | Expenditure |
|---|---|---|
| Feb. 28, 2025 | £124,570 | £102,099 |
| Feb. 29, 2024 | £107,219 | £95,890 |
| Feb. 28, 2023 | £84,952 | £78,737 |
Trustees
| Name | Appointed |
|---|---|
| Carmi Korine | July 15, 2024 |
| John Edward Sadler | July 2, 2021 |
| Philip David Mark Hurd | July 2, 2021 |
| Tess O'brien | Aug. 1, 2025 |